Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daniel Morillo-Giles"'
Autor:
Carlos Santonja, Daniel Morillo-Giles, Elena Prieto-Pareja, Carlos Soto-de Ozaeta, Cristina Serrano-del Castillo, Rocío Salgado-Sánchez, Ana-Wu-Yang Yi-Shi, Rebeca Manso, Socorro María Rodríguez-Pinilla
Publikováno v:
Medicina, Vol 59, Iss 9, p 1628 (2023)
Anaplastic large cell lymphoma (ALCL) with leukaemic presentation (either ab initio or along the course of the disease) has been rarely reported. Irrespective of ALK expression in the neoplastic cells, it features a dismal prognosis. We report a rare
Externí odkaz:
https://doaj.org/article/6456dd5253414fb3afb4ef0b222a3e03
Autor:
Soraya Carrancio, Wen-Chi Chou, Alberto Risueño, Carla Guarinos, Gonzalo Lopez, Jean-Marie Michot, Loretta J. Nastoupil, Julio Chavez, Cecilia Carpio, Silvia Ferrari, Tatyana A. Feldman, Daniel Morillo Giles, Antonio Pinto, Danielle Greenawalt, Daniel W. Pierce, Michael Pourdehnad
Publikováno v:
Blood. 140:6455-6457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c84908bd759975b50fcc53f42e6305a9
https://doi.org/10.1182/blood-2022-159585
https://doi.org/10.1182/blood-2022-159585
Autor:
Al-Ola Abdallah, Andrew J Cowan, Xavier Leleu, Cyrille Touzeau, Brea Lipe, Eva Medvedova, Caitlin Costello, Jens Hillengass, P. Leif Bergsagel, Raya Mawad, Henning Schade, Daniel Morillo Giles, Albert Oriol, Yifah Yaron, Patrick P Ng, Sumit Madan
Publikováno v:
Blood. 140:7284-7285
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c579ad0e7449725f156f6b1170bebdf
https://doi.org/10.1182/blood-2022-159665
https://doi.org/10.1182/blood-2022-159665
Autor:
Thomas J. Prior, Donna E. Reece, Paula Rodriguez-Otero, Amrita Krishnan, Maria-Victoria Mateos, Bhagirathbhai Dholaria, Parameswaran Hari, Daniel Morillo Giles, Niels W.C.J. van de Donk, Jesús F. San-Miguel, Mark Wade, Ajai Chari, Hartmut Goldschmidt, Alfred L. Garfall, Elham Askari, K. Martin Kortuem, Jenna D. Goldberg, Saad Z. Usmani, Cesar Rodriguez, Raluca Verona, Brendan M. Weiss, Nizar J. Bahlis, Albert Oriol, Shun Xin Wang Lin, Thomas Martin
Publikováno v:
Blood. 138:161-161
Introduction: Novel agents are needed for multiple myeloma (MM), which remains incurable with most patients (pts) relapsing or becoming refractory to standard therapies. Talquetamab (Tal) is a bispecific antibody that binds to G protein-coupled recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e21e6992e7bb9ac4a3e021c2ee7cda56
https://doi.org/10.1182/blood-2021-148813
https://doi.org/10.1182/blood-2021-148813
Autor:
Ralph Wäsch, Jesús F. San-Miguel, Hartmut Goldschmidt, Laura Rosiñol, Niels W.C.J. van de Donk, Donna E. Reece, Cesar Rodriguez, Ajai Chari, Thomas J. Prior, Maria-Victoria Mateos, Anna Sureda, Shun Xin Wang Lin, Jenna D. Goldberg, Katja Weisel, Paula Rodriguez-Otero, Amrita Krishnan, Parameswaran Hari, Mark Wade, Albert Oriol, Raluca Verona, Bhagirathbhai Dholaria, Thomas Martin, Elham Askari, Daniel Morillo Giles, Brendan M. Weiss
Publikováno v:
Blood. 138:1647-1647
Introduction: Teclistamab (Tec) is a B-cell maturation antigen × CD3 T-cell redirecting bispecific antibody. In the phase 1 MajesTEC-1 trial in patients (pts) with heavily pretreated relapsed/refractory multiple myeloma (RRMM), Tec monotherapy was w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e722a70e91f32fc9dafdd346cc22f62
https://doi.org/10.1182/blood-2021-148723
https://doi.org/10.1182/blood-2021-148723
Autor:
Cecilia Carpio, Alejandro Martín, Xin Wei, Daniel O. Persky, Charalambos Andreadis, Ying Fei Li, Kristen Hege, Pau Abrisqueta, Michael R. Burgess, Daniel Morillo Giles, Raul Cordoba, Juan-Manuel Sancho, Marlene Zuraek, Scott F. Huntington
Publikováno v:
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background: Cluster of differentiation 47 (CD47), a widely expressed cell-surface ligand,is overexpressed in various malignancies and is correlated with worse outcomes in NHL. Interaction of CD47 and signal regulatory protein-α (SIRPα) delivers an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1a09a313cdead924e3b9321afb3461
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2901
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2901
Publikováno v:
Medicina clinica. 148(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7a22ac97fed4cf8a3f022e3751d020
https://pubmed.ncbi.nlm.nih.gov/27431888
https://pubmed.ncbi.nlm.nih.gov/27431888
Publikováno v:
Medicina Clínica. 148:338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a100af783e00cdd81f07ad13f855b2fd
https://doi.org/10.1016/j.medcli.2016.05.028
https://doi.org/10.1016/j.medcli.2016.05.028